Valuation Pharmaids Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. 06:02:27 2026-08-13 EDT			5-day change	1st Jan Change
33.99 ^INR	-2.52%		-4.25%	-28.68%

08-12	Pharmaids Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-29	Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2020	2021	2022	2023	2024	2025
Market Cap ¹	46.4	115.3	129	488.8	1,834	2,422
Change	-	148.44%	11.9%	278.93%	275.2%	32.06%
Enterprise Value (EV) ¹	46.18	113.3	124.9	328.2	1,871	2,790
Change	-	145.28%	10.28%	162.73%	470.15%	49.11%
P/E	150x	124x	89.4x	-3.72x	-14.8x	-22.5x
PBR	0.55x	1.35x	1.49x	2.09x	2.55x	4.08x
PEG	-	1x	1.6x	0x	0.4x	1.7x
Capitalization / Revenue	-	1,348,141x	3,274,561x	-	12,135,482x	12,411,040x
EV / Revenue	-	-	-	-	-	-
EV / EBITDA	-13.8x	106x	91.1x	-3.45x	-13.8x	-21.8x
EV / EBIT	-12.3x	182x	97.7x	-3.44x	-12.7x	-18.5x
EV / FCF	1.33x	32x	37x	-4.61x	-6.08x	-15.2x
FCF Yield	75.5%	3.13%	2.71%	-21.7%	-16.5%	-6.6%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	0.03	0.09	0.14	-5.86	-3.507	-3.056
Distribution rate	-	-	-	-	-	-
Net sales	-	85.51	39.39	-	151.1	195.1
EBITDA ¹	-3.355	1.069	1.371	-95.2	-135.5	-128
EBIT ¹	-3.743	0.6209	1.279	-95.37	-146.9	-151.1
Net income ¹	0.3353	0.9331	1.451	-75.56	-79.68	-107.8
Net Debt ¹	-0.2178	-2.003	-4.074	-160.6	37.29	368.3
Reference price ²	4.50	11.18	12.51	21.81	52.00	68.67
Nbr of stocks (in thousands)	10,311	10,311	10,311	22,411	35,268	35,268
Announcement Date	8/21/20	8/30/21	7/23/22	8/31/23	9/3/24	8/29/25

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
PHARMAIDS PHARMACEUTICALS LIMITED	-	-	-	-	12.89M
ELI LILLY AND COMPANY	34.6x	12.64x	25.73x	0.57%	1,088B
JOHNSON & JOHNSON	29.02x	-	-	2.06%	629B
ABBVIE INC.	31.76x	7.4x	15.37x	2.76%	440B
ROCHE HOLDING AG	20.37x	4.83x	11.97x	2.73%	359B
NOVARTIS AG	21.72x	5.63x	14.03x	2.85%	291B
ASTRAZENECA PLC	20.24x	4.18x	11.87x	2.1%	245B
AMGEN INC.	26.11x	6.86x	12.2x	2.42%	225B
NOVO NORDISK A/S	13.56x	4.86x	10.12x	3.76%	204B
GILEAD SCIENCES, INC.	-42.19x	6.04x	34.06x	2.43%	168B
Average	17.24x	6.55x	16.92x	2.41%	364.92B
Weighted average by Cap.	24.66x	8.26x	18.73x	1.97%